Mannitol efficacy in ovarian hyper stimulation syndrome
Phase 3
Recruiting
- Conditions
- Ovarian hyper stimulation syndrome.Hyperstimulation of ovaries
- Registration Number
- IRCT20180305038953N1
- Lead Sponsor
- Sarem Fertility and Infertility Research Center (SAFIR)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Severe ovarian htper stimulation syndrome
Exclusion Criteria
Patient dissatisfaction to participate in the study
History of / sensitivity to the used drug
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Abdominal girth. Timepoint: Every morning. Method of measurement: Centimeter.;Weight. Timepoint: Every morning. Method of measurement: Digital scale; kilogram.;Hematocrite. Timepoint: Every 8 to 24 hours based on clinical severity of symptoms. Method of measurement: Colormetry; Percent.;Serum creatinine. Timepoint: Every 8 to 24 hours based on clinical severity of symptoms. Method of measurement: Milligram/deciliter.;Serum sodium level. Timepoint: Every 8 to 24 hours based on clinical severity of symptoms. Method of measurement: Ion Selective Electrode (ISE); millimol/milliliter.;Serum potassium level. Timepoint: Every 8 to 24 hours based on clinical severity of symptoms. Method of measurement: Ion Selective Electrode (ISE); millimol/milliliter.
- Secondary Outcome Measures
Name Time Method Duration of hospitalization. Timepoint: At the end of hospitalization. Method of measurement: Number of days.;Total cost of medicine used. Timepoint: At the end of drug therapy. Method of measurement: Total cost of medicine in Rials.